01—Abstract
Summary
Summary of the 10-K filed February 8, 2024. Cited figures are marked; the original filing is the authoritative source.
Philip Morris International Inc. (PMI) has filed its 2023 10-K, highlighting a transformative year marked by the integration of Swedish Match and strategic investments in a smoke-free future.
The company reported a net revenue increase of 10.7% to $35.2 billiona, driven by strong pricing and growth in heated tobacco unit (HTU) volume, despite a slight decline in cigarette volume. Diluted EPS saw a decrease of 13.6% to $5.02, impacted by significant acquisition-related costs, impairment charges, and war-related expenses. PMI's strategic pivot towards smoke-free products (SFPs) continues, with SFPs contributing substantially to net revenues.
The acquisition of Swedish Match has significantly expanded PMI's oral nicotine portfolio, notably with the ZYN brand in the U.S. Looking ahead, PMI is focused on accelerating its smoke-free transformation, which includes continued investment in product development, scientific substantiation, and market expansion. Key risks remain related to regulatory environments, particularly concerning RRPs, and the ongoing geopolitical instability in Eastern Europe. The company also announced a global patent settlement with British American Tobacco (BAT), resolving all ongoing patent infringement litigation related to heated tobacco and vapor products, which is expected to allow for continued product innovation.
02—Key points
Key Highlights
- Net revenues increased by 10.7% to $35.2 billion, driven by favorable pricing and a 14.7% increase in Heated Tobacco Unit (HTU) shipments.
- Diluted EPS decreased by 13.6% to $5.02, primarily due to significant charges including asset impairments, acquisition accounting adjustments, and war-related costs.
- The acquisition of Swedish Match AB contributed substantially to revenue and expanded PMI's oral nicotine portfolio, particularly the ZYN brand in the U.S.
- Smoke-free products (SFPs) represented a growing portion of net revenues, totaling $12.8 billion in 2023.
- PMI entered into a global settlement agreement with British American Tobacco (BAT) to resolve all ongoing patent infringement litigation related to heated tobacco and vapor products.
- The company continues to invest heavily in its smoke-free transformation, with R&D for its smoke-free portfolio constituting 99% of total R&D expenses.
- Despite strong net revenue growth, operating income decreased by 5.6% due to various one-off charges and increased operating costs, including inflationary pressures.
03—One dollar
Follow one dollar
Of each $1.00 of revenue in FY2023, Philip Morris International Inc. kept $0.22.
- Revenue$35.17B100.0%
- Cost of revenue−$12.89B36.7%
- Gross profit$22.28B63.3%
- Operating costs−$10.72B30.5%
- Operating income$11.56B32.9%
- Interest, other & tax−$3.74B10.6%
- Net income$7.81B22.2%
Where FY2023 revenue went
$35.17B- Cost of revenue: $12.89B, 37% of revenue
- Other operating costs: $10.02B, 28% of revenue
- Net income: $7.81B, 22% of revenue
- R&D: $709.0M, 2.0% of revenue
- Interest, other & tax: $3.74B, 11% of revenue
Kept 22% as net income
Full revenue history →04—Financials
Financial Highlights
Figures from 10-KFY2023filed February 8, 2024Financial Statements
FY2023 against FY2022
| Line item | FY2023FY2022 | Change |
|---|---|---|
| Revenue | $35.17B$31.76B | +10.7% |
| Cost of Revenue | $12.89B$11.40B | +13.1% |
| Gross Profit | $22.28B$20.36B | +9.4% |
| R&D Expenses | $709.00M$642.00M | +10.4% |
| Operating Income | $11.56B$12.25B | −5.6% |
| Interest Expense | $1.53B$768.00M | +98.7% |
| Net Income | $7.81B$9.05B | −13.6% |
| EPS (Basic) | $5.02$5.82 | −13.7% |
| EPS (Diluted) | $5.02$5.81 | −13.6% |
| Shares Outstanding (Basic) | 1.55B1.55B | +0.1% |
| Shares Outstanding (Diluted) | 1.55B1.55B | +0.1% |
05—Questions
Frequently Asked Questions
What was the financial performance of Philip Morris International in 2023?
In 2023, Philip Morris International reported a net revenue increase of 10.7% to $35.2 billion, primarily driven by higher pricing and increased shipment volumes of heated tobacco units (HTUs). However, diluted earnings per share (EPS) decreased by 13.6% to $5.02 due to significant charges including asset impairments, acquisition-related costs from Swedish Match, and costs associated with the war in Ukraine. Operating income also saw a decline of 5.6%.
How is the Swedish Match acquisition impacting PMI's business?
The acquisition of Swedish Match AB, completed in late 2022, has significantly contributed to PMI's revenue and market position, particularly in the oral nicotine category with its leading ZYN brand in the U.S. Smoke-free products, including those from Swedish Match, now account for a substantial portion of PMI's net revenue, accelerating the company's transformation towards a smoke-free future.
What are the key risks and challenges facing Philip Morris International?
PMI faces several key risks and challenges, including: stringent government regulations on tobacco and reduced-risk products (RRPs), potential for increased excise taxes, intense competition, the potential for unfavorable litigation outcomes, and geopolitical instability, particularly related to its operations in Russia and Ukraine. The company is also exposed to currency fluctuations and inflationary pressures affecting operating costs.
What is PMI's strategy regarding smoke-free products?
PMI's core strategy is to transition towards a smoke-free future by developing, scientifically substantiating, and commercializing reduced-risk products (RRPs). This includes a significant focus on its IQOS heat-not-burn platform and the ZYN oral nicotine brand. The company is committed to investing heavily in R&D for these products and educating adult smokers about switching to less harmful alternatives.
06—Continue